Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

University of Colorado - Product Pipeline Analysis

VIEWS: 100 PAGES: 38

University of Colorado - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the University of Colorado portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reaso

More Info
  • pg 1
									                                    University of Colorado - Product Pipeline Analysis
     Reference Code: GDMEPHPE72684PD                                                                                             Publication Date: NOV 2010



     Company Snapshot                                                          Company Overview
     Key Information
                                                                               University of Colorado is engaged in offering a range of academic programs
      University of Colorado, Key Facts                                        for undergraduate, graduate, and professional study. It offers 18 distance
                                                                               education degree programs. The company has 4 campus at four different
      Web Address                            www.cu.edu
                                                                               location like Boulder, Colorado Springs, Denver and Anschutz Medical
      Industry                               Energy and Utilities              Campus, through which its offers educational services. Each campus has over
      Source:Primary / Secondary Research                                      4 colleges which offers education programs in different areas.
      GlobalData




     University of Colorado Pipeline Products

      University of Colorado Key Pipeline Products by                          University of Colorado Key Pipeline Products by Therapy Area
      Equipment Type
     Equipment Type                          No of Products                    Therapy Area                                               No of Products
     Immuno Chemistry                                   11                     Influenza                                                              2
     Neurological Diagnostic Devices                     2                     Lung cancer                                                               2
     Infectious Immunology                                           2         Acute myeloid leukemia                                                    1
     Oncology Devices                                                1         Atherosclerosis                                                           1
     Neurostimulation Devices                                        1         Cancer                                                                    1
     Microbiology Culture                                            1         Cardiomyopathy                                                            1
     Interventional Cardiology                                       1         Chicken pox, Shingles                                                     1
     Source: Primary / Secondary Research                                      Source: Primary / Secondary Research
     GlobalData                                                                GlobalData


     University of Colorado Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData
      Others indicates :- Infectious Immunology - 8%, Immuno Chemistry - 44%


     University of Colorado Key Pipeline Products by                           University of Colorado Key Pipeline Products by Trial Phase
     Development Stage
     Developmental Stage                    No of Products                     Trial Phase                                                No of Products
     Clinicals                                          8                      Phase IV                                               -
     Pre-Clinicals                                      2                      Phase III                                              -
     Early development                                                         Phase II                                               -
                                                                    18
     Source: Primary / Secondary Research                                      Phase I                                                -
     GlobalData                                                                Source: Primary / Secondary Research
                                                                               GlobalData
                                                                               Note : (-) indicates 'Not Available'




University of Colorado - Product Pipeline Analysis                                                                              Reference Code: GDMEPHPE72684PD

Source : www.globalcompanyintelligence.com                                                                                                                    Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 4
     List of Figures......................................................................................................................................................................................................................................................................... 5
     Key Facts ............................................................................................................................................................................................................................................................................... 6
     University of Colorado - Major Products and Services........................................................................................................................................................................................................... 7
           University of Colorado Pipeline Products by Equipment Type ........................................................................................................................................................................................ 8
           University of Colorado Pipeline Products by Development Stage................................................................................................................................................................................. 10
           University of Colorado Pipeline Products by Therapy Area........................................................................................................................................................................................... 12
           ActiveInvasive EEG ....................................................................................................................................................................................................................................................... 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ................................................................................................................................................................................................................................................. 14
                 Product Patent Details ............................................................................................................................................................................................................................................ 14
           Activity monitor for bedridden patients........................................................................................................................................................................................................................... 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ................................................................................................................................................................................................................................................. 15
           Beryllium Toxicity assay ................................................................................................................................................................................................................................................ 15
                 Product Status......................................................................................................................................................................................................................................................... 15
                 Product Description ................................................................................................................................................................................................................................................. 15
           Biocompatible Neural Electrode .................................................................................................................................................................................................................................... 15
                 Product Status......................................................................................................................................................................................................................................................... 15
                 Product Description ................................................................................................................................................................................................................................................. 15
                 Product Patent Details ............................................................................................................................................................................................................................................ 16
           Cancer cell surface markers assay................................................................................................................................................................................................................................ 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           CBS gene mutations test ............................................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Patent Details ............................................................................................................................................................................................................................................ 17
           Diagnostic DNA Microarray-AVR chip ........................................................................................................................................................................................................................... 18
                 Product Status......................................................................................................................................................................................................................................................... 18
                 Product Description ................................................................................................................................................................................................................................................. 18
           Diagnostic DNA Microarray-FluChip-B .......................................................................................................................................................................................................................... 18
                 Product Status......................................................................................................................................................................................................................................................... 18
                 Product Description ................................................................................................................................................................................................................................................. 18
           Difficult Airway Tube ...................................................................................................................................................................................................................................................... 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           DNA Biomarker Assay-Cardiomyopathy........................................................................................................................................................................................................................ 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           Esophageal inflammation diagnostic test ...................................................................................................................................................................................................................... 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
           Fibrinolysis-thrombosis assay........................................................................................................................................................................................................................................ 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
           MicroFlex Endoscope .................................................................................................................................................................................................................................................... 21
                 Product Status......................................................................................................................................................................................................................................................... 21
                 Product Description ................................................................................................................................................................................................................................................. 21
           MicroRNA assay- Lung cancer ...................................................................................................................................................................................................................................... 21
                 Product Status......................................................................................................................................................................................................................................................... 21
                 Product Description ................................................................................................................................................................................................................................................. 21
           MicroRNA assay-Heart disease..................................................................................................................................................................................................................................... 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
           MicroRNA assay-Non-small Cell Lung Cancer.............................................................................................................................................................................................................. 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
           MicroRNA Assay-Pulmonary Arterial Disease............................................................................................................................................................................................................... 23

University of Colorado - Product Pipeline Analysis                                                                                                                                                                                         Reference Code: GDMEPHPE72684PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Molecular Probe Assay-Acute Myeloid Leukemia ......................................................................................................................................................................................................... 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Myelin-Mapping MRI System......................................................................................................................................................................................................................................... 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description .................................................................................................................................................................................................
								
To top